Sinovac Biotech received a production license for RabEnd, its inactivated animal rabies vaccine, from China's Ministry of Agriculture, the final step in the approval process for the vaccine. Sinovac has already assembled a sales force to help launch the product. The vaccine will be the first of Sinovac’s planned foray into animal health vaccines. More details....

Stock Symbol: (NSDQ: SVA)     Share this with colleagues: